Detalhe da pesquisa
1.
Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma-a real-world multicenter retrospective cohort study.
Ann Hematol
; 102(8): 2127-2136, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37335322
2.
Comparing end-of-life care of hematologic malignancy versus solid tumor patients in a tertiary care center.
Eur J Haematol
; 111(4): 528-535, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37385825
3.
Early integration of palliative care for patients with haematological malignancies.
Br J Haematol
; 199(1): 14-30, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35670630
4.
Enzyme replacement therapy leading to improvement in myeloma indices in a patient with concomitant Gaucher disease.
Intern Med J
; 52(5): 872-875, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35538014
5.
Willingness and concerns of transfusion-dependent hematological patients toward the option of home transfusion therapy.
Palliat Med
; 35(5): 927-932, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33761783
6.
Attitudes toward death and death acceptance among hemato-oncologists: An Israeli sample.
Palliat Support Care
; 19(5): 587-591, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33295274
7.
Real-world data on incidence, clinical characteristics and outcome of patients with macrofocal multiple myeloma (MFMM) in the era of novel therapies: A study of the Greco-Israeli collaborative myeloma working group.
Am J Hematol
; 95(5): 465-471, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32048329
8.
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group.
Am J Hematol
; 95(6): 604-611, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32096887
9.
Low-dose fludarabine and cyclophosphamide combined with standard dose rituximab (LD-FCR) is an effective and safe regimen for elderly untreated patients with chronic lymphocytic leukemia: The Israeli CLL study group experience.
Hematol Oncol
; 37(2): 185-192, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30756414
10.
A new risk model to predict time to first treatment in chronic lymphocytic leukemia based on heavy chain immunoparesis and summated free light chain.
Eur J Haematol
; 103(4): 335-341, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31278876
11.
Persistently low lymphocyte counts after FCR therapy for chronic lymphocytic leukemia are associated with longer overall survival.
Hematol Oncol
; 36(1): 128-135, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28639416
12.
Outcomes of second-line treatment after fludarabine cyclophosphamide and rituximab in patients with chronic lymphocytic leukemia outside clinical trials.
Eur J Haematol
; 101(3): 399-406, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29949186
13.
Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real-World" study.
Am J Hematol
; 98(2): E24-E27, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36349541
14.
Neutrophil-lymphocyte ratio at diagnosis is an independent prognostic factor in patients with nodular sclerosis Hodgkin lymphoma: results of a large multicenter study involving 990 patients.
Hematol Oncol
; 35(4): 561-566, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27791277
15.
The risk of bleeding in patients receiving ibrutinib combined with novel direct oral anticoagulants.
Br J Haematol
; 189(2): e31-e33, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32150642
16.
Richter's transformation to diffuse large B-cell lymphoma: a retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group.
Am J Hematol
; 89(11): E218-22, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25110869
17.
Predictability: A new distinguishing feature of cancer?
PLoS One
; 19(6): e0305181, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38865416
18.
Significance of bone marrow reticulin fibrosis in chronic lymphocytic leukemia at diagnosis: a study of 176 patients with prognostic implications.
Cancer
; 119(10): 1853-9, 2013 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23423815
19.
Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: a retrospective multicenter study.
Am J Hematol
; 88(2): 130-4, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23345248
20.
Plasmapheresis in a Patient with Sarcoidosis Who Developed Multiple Myeloma and Massive Free Kappa Light Chains Nephropathy.
Isr Med Assoc J
; 20(5): 324-326, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29761682